Citalopram HBR 20 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DR26F71SW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,493
Award facts
- Contract value 100% obligated
- $10,493.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Citalopram HBR 20 mg tablets (500 count) under a firm fixed-price contract with a ceiling value of $10,493.11. The contract, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal vendor through its extensive portfolio of medical product deliveries to the Defense Logistics Agency and its Medical Supply Chain. The company's federal contract awards demonstrate versatility in fulfilling diverse medical supply needs, ranging from specialty medications and brand-name and generic drugs to vaccines and medical devices across multiple therapeutic domains. This award supports the military healthcare system's pharmaceutical supply chain and aligns with the DLA's strategic approach to maintaining robust, competitively awarded relationships with established pharmaceutical distributors capable of meeting federal medical procurement requirements globally.
Quick answers
Who was awarded contract SPE2DR26F71SW?
SPE2DR26F71SW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26F71SW worth?
The government has obligated $10,493 on SPE2DR26F71SW.
Is contract SPE2DR26F71SW an order under another contract?
Yes. SPE2DR26F71SW is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F71SW competed?
The extent of competition for SPE2DR26F71SW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award